论文部分内容阅读
目的观察静脉注射地尔硫控制快速心房颤动(房颤)心室率的疗效及其安全性。方法66例快速房颤患者随机分为两组,治疗组34例静脉注射地尔硫,对照组32例静脉注射西地兰。结果治疗组及对照组总有效率分别为94.11%、68.75%,治疗组疗效明显优于对照组,差异有统计学意义(P<0.05)。无严重副作用发生。结论地尔硫较西地兰能更迅速、有效、安全地控制快速房颤的心室率。
Objective To observe the efficacy and safety of intravenous diltiazem in the control of ventricular rate in patients with rapid atrial fibrillation (AF). Methods Sixty-six patients with rapid AF were randomly divided into two groups: 34 in the treatment group received intravenous diltiazem and 32 in the control group received intravenous cedilanid. Results The total effective rates of the treatment group and the control group were 94.11% and 68.75%, respectively. The curative effect of the treatment group was obviously better than that of the control group (P <0.05). No serious side effects occur. Conclusion Diltiazem can control the ventricular rate of AF more rapidly, effectively and safely than cedilanid.